Form 4: LifeStance CFO's RSU Vesting Leads to Tax Withholding

LifeStance Health Group's CFO, Ryan McGroarty, had 24,255 shares withheld for tax obligations following the vesting of restricted stock units.

Summary

• Ryan McGroarty, Chief Financial Officer and Treasurer of LifeStance Health Group, Inc., reported a change in beneficial ownership.
• On March 24, 2026, 24,255 shares of common stock were withheld by the issuer.
• This withholding was to satisfy tax obligations related to the net settlement of restricted stock units (RSUs) that vested on the same date.
• The shares were valued at $6.45 each for tax purposes.
• Following this transaction, McGroarty beneficially owns 772,235 shares of common stock directly.
• The transaction was not an open-market sale but a reduction of shares issued upon RSU settlement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it's a reduction in shares, it's for tax purposes related to vested RSUs, indicating the executive met performance criteria and is retaining a significant stake.

Positives

• The vesting of restricted stock units indicates that performance or time-based conditions were met, reflecting positively on the company's compensation structure and potentially executive retention.
• The transaction is a tax-related withholding, not a discretionary open-market sale by the insider, which is generally viewed more neutrally than a sale.

Negatives

• A reduction of 24,255 shares from the reporting person's direct beneficial ownership, even if for tax purposes, slightly decreases their direct stake.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to a past insider transaction.

Management Comments

• Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ('RSUs') that vested on March 24, 2026.
• The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Industry Context

StockSavvy.ai notes that routine insider transactions like RSU vesting and associated tax withholdings are common across all industries, particularly in growth-oriented healthcare companies like LifeStance, as part of executive compensation packages. This specific filing does not indicate any unique industry trends or competitive shifts.

Comparison to Industry Standards

• This type of RSU vesting and tax withholding is a standard practice in executive compensation across publicly traded companies.
• For example, similar practices are observed at mental health providers like Talkspace (TALK) or Bright Health Group (BHG) where equity compensation is a significant component of executive pay.
• The withholding price of $6.45 per share reflects the market value at the time of vesting for tax purposes, which is consistent with how such transactions are typically handled.

Related Party Transactions

• The transaction involves the company (issuer) and its Chief Financial Officer (reporting person) in the context of executive compensation, specifically the vesting and tax withholding of restricted stock units.

Stakeholder Impact

• Shareholders: Minimal direct impact. The transaction is a routine administrative event related to executive compensation and does not signal a change in company fundamentals or strategy. It confirms the CFO's continued equity stake.
• Management: The CFO continues to hold a substantial equity stake, aligning interests with shareholders.

Key Dates

Recommendation

This Form 4 reports a routine tax-related transaction for an executive's vested restricted stock units. It does not provide new fundamental information about LifeStance Health Group's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The CFO continues to hold a significant number of shares, indicating continued alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

LifeStance Health Group, LFST, Form 4, Insider Transaction, Ryan McGroarty, CFO, Restricted Stock Units, RSU, Tax Withholding, Beneficial Ownership